The Europe Non-invasive Aesthetic Treatment Market would witness market growth of 14.2% CAGR during the forecast period (2021-2027).
Some of the important factors must be considered while going for a non-invasive treatment. It is required to make sure that the patient is provided with the top up treatments. The body will use the injected substances for a long time (between 6-12 months depending on the individual’s metabolism) due to which having the top up treatment is more preferred in order to ensure safety.
Non-invasive treatments such as laser procedures, radio frequency treatments, and others, would result in minimal or no pain & discomfort to individuals. However, some treatments may have a bit of side effects but they usually disappear within a couple of days. Also, the non-invasive procedures do not include scalpels or incisions. This makes it clear, there is no requirement of stiches and thus, no scars would occur.
The demand for cosmetic procedures is increasing significantly in the Europe region. This is because of the efficient healthcare facilities in the region. Rising consciousness regarding the overall fitness & appearance has increased the adoption of non-invasive aesthetic treatments. The most commonly practiced cosmetic treatments in the United Kingdom are breast augmentation, breast reduction and the laser treatment.
Furthermore, the government of the United Kingdom has not defined any regulations over non-surgical laser treatment practices. This means that there are no restrictions that laser tattoo removal or hair removal treatment practices can be done by only a particular group and which equipment is to be used for such treatments. This encourages the providers to open MedSpa & private clinics for these treatments.
The Germany market dominated the Europe Non-invasive Aesthetic Treatment Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $8.5 billion by 2027. The UK market is poised to grow at a CAGR of 13.4% during (2021 - 2027). Additionally, The France market would display a CAGR of 15% during (2021 - 2027).
Based on End-Use, the market is segmented into MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic. Based on Procedure, the market is segmented into Injectables, Skin Rejuvenation, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Non-invasive Aesthetic Treatment Market Size will Hit $116.4 Billion by 2027, at a CAGR of 13.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Alma Lasers Ltd., Allergan PLC, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Johnson & Johnson, Candela Medical Corporation, Bausch Health Companies, Inc., Cutera, Inc., Lumenis Ltd., and Hologic, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End-use
- MedSpa
- Hospital/Surgery Center
- Traditional Spa
- HCP Owned Clinic
By Procedure
- Injectables
- Skin Rejuvenation
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Alma Lasers Ltd.
- Allergan PLC
- Galderma S.A.
- Merz Pharma GmbH & Co. KGaA
- Johnson & Johnson
- Candela Medical Corporation
- Bausch Health Companies, Inc.
- Cutera, Inc.
- Lumenis Ltd.
- Hologic, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Non-invasive Aesthetic Treatment Market, by End-use
1.4.2 Europe Non-invasive Aesthetic Treatment Market, by Procedure
1.4.3 Europe Non-invasive Aesthetic Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Product Launches and Product Expansions
3.2.2 Acquisition and Mergers
3.2.3 Partnerships, Collaborations and Agreements
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Sep – 2022, Feb) Leading Players
Chapter 4. Europe Non-invasive Aesthetic Treatment Market by End-use
4.1 Europe MedSpa Market by Country
4.2 Europe Hospital/Surgery Center Market by Country
4.3 Europe Traditional Spa Market by Country
4.4 Europe HCP Owned Clinic Market by Country
Chapter 5. Europe Non-invasive Aesthetic Treatment Market by Procedure
5.1 Europe Injectables Market by Country
5.2 Europe Skin Rejuvenation Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Non-invasive Aesthetic Treatment Market by Country
6.1 Germany Non-invasive Aesthetic Treatment Market
6.1.1 Germany Non-invasive Aesthetic Treatment Market by End-use
6.1.2 Germany Non-invasive Aesthetic Treatment Market by Procedure
6.2 UK Non-invasive Aesthetic Treatment Market
6.2.1 UK Non-invasive Aesthetic Treatment Market by End-use
6.2.2 UK Non-invasive Aesthetic Treatment Market by Procedure
6.3 France Non-invasive Aesthetic Treatment Market
6.3.1 France Non-invasive Aesthetic Treatment Market by End-use
6.3.2 France Non-invasive Aesthetic Treatment Market by Procedure
6.4 Russia Non-invasive Aesthetic Treatment Market
6.4.1 Russia Non-invasive Aesthetic Treatment Market by End-use
6.4.2 Russia Non-invasive Aesthetic Treatment Market by Procedure
6.5 Spain Non-invasive Aesthetic Treatment Market
6.5.1 Spain Non-invasive Aesthetic Treatment Market by End-use
6.5.2 Spain Non-invasive Aesthetic Treatment Market by Procedure
6.6 Italy Non-invasive Aesthetic Treatment Market
6.6.1 Italy Non-invasive Aesthetic Treatment Market by End-use
6.6.2 Italy Non-invasive Aesthetic Treatment Market by Procedure
6.7 Rest of Europe Non-invasive Aesthetic Treatment Market
6.7.1 Rest of Europe Non-invasive Aesthetic Treatment Market by End-use
6.7.2 Rest of Europe Non-invasive Aesthetic Treatment Market by Procedure
Chapter 7. Company Profiles
7.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Approvals and Agreements:
7.1.5.3 Acquisitions and Mergers:
7.1.5.4 Partnerships, Collaborations and Agreements:
7.2 Allergan PLC (AbbVie)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisitions and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.2.5.3 Approvals and Trials:
7.3 Galderma S.A.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations and Agreements:
7.4 Merz Pharma GmbH & Co. KGaA
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Product Launches and Product Expansions:
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental &Regional Analysis
7.5.4 Research & Development Expenses
7.6 Candela Medical Corporation
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisitions and Mergers:
7.6.2.2 Partnerships, Collaborations and Agreements:
7.7 Bausch Health Companies, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Cutera, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Product Launches and Product Expansions:
7.9 Lumenis Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product Launches and Product Expansions:
7.10. Hologic, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisitions and Mergers:
7.10.5.2 Product Launches and Product Expansions:
TABLE 1 Europe Non-invasive Aesthetic Treatment Market, 2017 - 2020, USD Million
TABLE 2 Europe Non-invasive Aesthetic Treatment Market, 2021 - 2027, USD Million
TABLE 3 Product Launches And Product Expansions – Non-invasive Aesthetic Treatment Market
TABLE 4 Acquisition and Mergers – Non-invasive Aesthetic Treatment Market
TABLE 5 Partnerships, Collaborations and Agreements – Non-invasive Aesthetic Treatment Market
TABLE 6 Approvals and Trials – Non-invasive Aesthetic Treatment Market
TABLE 7 Europe Non-invasive Aesthetic Treatment Market by End-use, 2017 - 2020, USD Million
TABLE 8 Europe Non-invasive Aesthetic Treatment Market by End-use, 2021 - 2027, USD Million
TABLE 9 Europe MedSpa Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe MedSpa Market by Country, 2021 - 2027, USD Million
TABLE 11 Europe Hospital/Surgery Center Market by Country, 2017 - 2020, USD Million
TABLE 12 Europe Hospital/Surgery Center Market by Country, 2021 - 2027, USD Million
TABLE 13 Europe Traditional Spa Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe Traditional Spa Market by Country, 2021 - 2027, USD Million
TABLE 15 Europe HCP Owned Clinic Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe HCP Owned Clinic Market by Country, 2021 - 2027, USD Million
TABLE 17 Europe Non-invasive Aesthetic Treatment Market by Procedure, 2017 - 2020, USD Million
TABLE 18 Europe Non-invasive Aesthetic Treatment Market by Procedure, 2021 - 2027, USD Million
TABLE 19 Europe Injectables Market by Country, 2017 - 2020, USD Million
TABLE 20 Europe Injectables Market by Country, 2021 - 2027, USD Million
TABLE 21 Europe Skin Rejuvenation Market by Country, 2017 - 2020, USD Million
TABLE 22 Europe Skin Rejuvenation Market by Country, 2021 - 2027, USD Million
TABLE 23 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 24 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 25 Europe Non-invasive Aesthetic Treatment Market by Country, 2017 - 2020, USD Million
TABLE 26 Europe Non-invasive Aesthetic Treatment Market by Country, 2021 - 2027, USD Million
TABLE 27 Germany Non-invasive Aesthetic Treatment Market, 2017 - 2020, USD Million
TABLE 28 Germany Non-invasive Aesthetic Treatment Market, 2021 - 2027, USD Million
TABLE 29 Germany Non-invasive Aesthetic Treatment Market by End-use, 2017 - 2020, USD Million
TABLE 30 Germany Non-invasive Aesthetic Treatment Market by End-use, 2021 - 2027, USD Million
TABLE 31 Germany Non-invasive Aesthetic Treatment Market by Procedure, 2017 - 2020, USD Million
TABLE 32 Germany Non-invasive Aesthetic Treatment Market by Procedure, 2021 - 2027, USD Million
TABLE 33 UK Non-invasive Aesthetic Treatment Market, 2017 - 2020, USD Million
TABLE 34 UK Non-invasive Aesthetic Treatment Market, 2021 - 2027, USD Million
TABLE 35 UK Non-invasive Aesthetic Treatment Market by End-use, 2017 - 2020, USD Million
TABLE 36 UK Non-invasive Aesthetic Treatment Market by End-use, 2021 - 2027, USD Million
TABLE 37 UK Non-invasive Aesthetic Treatment Market by Procedure, 2017 - 2020, USD Million
TABLE 38 UK Non-invasive Aesthetic Treatment Market by Procedure, 2021 - 2027, USD Million
TABLE 39 France Non-invasive Aesthetic Treatment Market, 2017 - 2020, USD Million
TABLE 40 France Non-invasive Aesthetic Treatment Market, 2021 - 2027, USD Million
TABLE 41 France Non-invasive Aesthetic Treatment Market by End-use, 2017 - 2020, USD Million
TABLE 42 France Non-invasive Aesthetic Treatment Market by End-use, 2021 - 2027, USD Million
TABLE 43 France Non-invasive Aesthetic Treatment Market by Procedure, 2017 - 2020, USD Million
TABLE 44 France Non-invasive Aesthetic Treatment Market by Procedure, 2021 - 2027, USD Million
TABLE 45 Russia Non-invasive Aesthetic Treatment Market, 2017 - 2020, USD Million
TABLE 46 Russia Non-invasive Aesthetic Treatment Market, 2021 - 2027, USD Million
TABLE 47 Russia Non-invasive Aesthetic Treatment Market by End-use, 2017 - 2020, USD Million
TABLE 48 Russia Non-invasive Aesthetic Treatment Market by End-use, 2021 - 2027, USD Million
TABLE 49 Russia Non-invasive Aesthetic Treatment Market by Procedure, 2017 - 2020, USD Million
TABLE 50 Russia Non-invasive Aesthetic Treatment Market by Procedure, 2021 - 2027, USD Million
TABLE 51 Spain Non-invasive Aesthetic Treatment Market, 2017 - 2020, USD Million
TABLE 52 Spain Non-invasive Aesthetic Treatment Market, 2021 - 2027, USD Million
TABLE 53 Spain Non-invasive Aesthetic Treatment Market by End-use, 2017 - 2020, USD Million
TABLE 54 Spain Non-invasive Aesthetic Treatment Market by End-use, 2021 - 2027, USD Million
TABLE 55 Spain Non-invasive Aesthetic Treatment Market by Procedure, 2017 - 2020, USD Million
TABLE 56 Spain Non-invasive Aesthetic Treatment Market by Procedure, 2021 - 2027, USD Million
TABLE 57 Italy Non-invasive Aesthetic Treatment Market, 2017 - 2020, USD Million
TABLE 58 Italy Non-invasive Aesthetic Treatment Market, 2021 - 2027, USD Million
TABLE 59 Italy Non-invasive Aesthetic Treatment Market by End-use, 2017 - 2020, USD Million
TABLE 60 Italy Non-invasive Aesthetic Treatment Market by End-use, 2021 - 2027, USD Million
TABLE 61 Italy Non-invasive Aesthetic Treatment Market by Procedure, 2017 - 2020, USD Million
TABLE 62 Italy Non-invasive Aesthetic Treatment Market by Procedure, 2021 - 2027, USD Million
TABLE 63 Rest of Europe Non-invasive Aesthetic Treatment Market, 2017 - 2020, USD Million
TABLE 64 Rest of Europe Non-invasive Aesthetic Treatment Market, 2021 - 2027, USD Million
TABLE 65 Rest of Europe Non-invasive Aesthetic Treatment Market by End-use, 2017 - 2020, USD Million
TABLE 66 Rest of Europe Non-invasive Aesthetic Treatment Market by End-use, 2021 - 2027, USD Million
TABLE 67 Rest of Europe Non-invasive Aesthetic Treatment Market by Procedure, 2017 - 2020, USD Million
TABLE 68 Rest of Europe Non-invasive Aesthetic Treatment Market by Procedure, 2021 - 2027, USD Million
TABLE 69 Key Information – Alma Lasers Ltd.
TABLE 70 Key Information – Allergan PLC
TABLE 71 Key Information – Galderma S.A.
TABLE 72 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 73 Key information –Johnson & Johnson
TABLE 74 Key Information – Candela Medical Corporation
TABLE 75 key information – Bausch Health Companies, Inc.
TABLE 76 Key Information – Cutera, Inc.
TABLE 77 key Information – Lumenis Ltd.
TABLE 78 Key information – Hologic, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2017, Sep – 2022, Feb) Leading Players
FIG 5 Recent strategies and developments: Alma Lasers Ltd.
FIG 6 Recent strategies and developments: Allergan PLC (AbbVie)
FIG 7 Recent strategies and developments: Candela Medical Corporation